Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -817 | -1,680 | -3,502 | -1,086 | -1,245 |
| Depreciation Amortization | 84 | 508 | 96 | 337 | 722 |
| Accounts receivable | N/A | N/A | -3 | 11 | -5 |
| Other Working Capital | 185 | 216 | 86 | 116 | 201 |
| Other Operating Activity | 368 | 902 | 3,293 | 219 | 17 |
| Operating Cash Flow | $-180 | $-54 | $-30 | $-403 | $-311 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | N/A | -14 | -105 |
| Net Acquisitions | N/A | N/A | 6 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -35 |
| Investing Cash Flow | $-1 | $0 | $6 | $-14 | $-140 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 259 | 20 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 30 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 12 | 30 | 421 | 324 |
| Financing Cash Flow | $259 | $62 | $30 | $421 | $324 |
| Beginning Cash Position | 14 | 6 | N/A | 1 | 128 |
| End Cash Position | 92 | 14 | 6 | 6 | 1 |
| Net Cash Flow | $78 | $8 | $6 | $5 | $-127 |
| Free Cash Flow | |||||
| Operating Cash Flow | -180 | -54 | -30 | -403 | -311 |
| Capital Expenditure | -1 | 0 | N/A | -14 | -105 |
| Free Cash Flow | -182 | -54 | -30 | -417 | -416 |